Company intelligence / Profile preview

Caring Cross

Gaithersburg, Maryland, United Statescaringcross.org ↗
Ownership
Private
Development stage
Phase 1
01

Overview

Caring Cross has developed advanced platforms enabling decentralized, point-of-care manufacturing of CAR-T cell and stem cell gene therapies. Their technologies have been transferred to partners globally, including India’s first approved commercial CAR-T product via ImmunoACT. They focus on making these treatments affordable through innovative business models and local manufacturing partnerships. Clinical results from their platforms have demonstrated therapeutic benefits in trials conducted by partner centers.

Therapeutic areas
OncologyRare DiseasesInfectious Diseases
Modalities
CAR-T cell therapiesStem cell gene therapiesLentiviral vector-based gene therapy
Industry
Biotech
02

Drug pipeline

7 assets

duoCAR-T

2

6 more assets in the full pipeline.

03

Partnerships

ImmunoAdoptive Cell Therapy (ImmunoACT), India – commercialization of TriCAR-T therapy for leukemia/lymphoma in IndiaBurjeel Holdings – local manufacturing of CAR-T therapies across MENA region with a projected significant cost reduction compared to US/EU pricesThe Wellbeing Foundation Africa – advancing access to advanced biotherapeutics in Nigeria through local integration/manufacturingVector BioMed – supplies GMP lentiviral vectors used by Caring Cross ATMPs

Beyond the preview

Go deeper on Caring Cross.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caring Cross.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call